Wearable and AI-guided diet and exercise program for weight loss
Official title: Effectiveness of a Wearable Device and AI-Supported Diet and Exercise Intervention in Obese Adults-a Quasi-experimental Design Study
Run by National Taiwan University Hospital · NCT06630663 · Data updated 2026-11-12
This study will test whether adding a wearable device and AI apps to a personalized 6-month diet and exercise program helps overweight and obese adults (BMI ≥24 with obesity-related conditions) lose weight.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 2 sites (Taipei, Taipei and 1 other locations) |
| Status | Recruiting |
| Started | August 10, 2025 |
| Main results expected | January 10, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | September 15, 2026 |
| Trial ID | NCT06630663 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 20 or older with BMI ≥24 kg/m2 and at least one obesity-related comorbidity who can use a wearable device and smartphone app and attend clinic visits.
✕Probably not a fit
People with recent large weight changes, prior bariatric surgery, untreated psychiatric disorders, use of medications that affect body weight, or inability to use the device or return for clinic visits may not qualify or benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers at National Taiwan University Hospital recruited overweight and obese adults and collected baseline body composition and biochemical measures including circulating galectin‑1. Of 142 eligible participants, 98 entered a personalized 6‑month weight‑loss program and 44 served as controls; one group used a wearable device and AI apps alongside diet and exercise guidance while the other followed a standard program. Outcomes included weight loss, body composition changes, and biochemical markers related to adipose tissue and inflammation. Participants attended outpatient clinic visits for assessments throughout the 6‑month period.
Why it matters
Potential benefit: If successful, this approach could help overweight and obese adults lose more weight and improve body composition and related inflammatory markers such as galectin‑1.
How similar studies have gone: Other digital and wearable-based lifestyle interventions have produced modest but clinically meaningful weight loss in some trials, so the approach has supporting evidence but variable results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. At least 20 years of age 2. BMI ≥24 kg/m2 plus one or more obesity-related comorbidities such as hypertension, diabetes, hyperlipidemia, sleep apnea syndrome, or nonalcoholic fatty liver disease 3. Able to use a wearable device and an app 4. Able to sign the informed consent form after receiving a detailed explanation of the study Exclusion Criteria: 1. Unable to finish the self-administered questionnaires 2. Unable to complete body composition assessment (bioimpedance analysis and abdominal echo), hand grip test, and blood sampling 3. Unable to return to our clinics at the scheduled time
Where it's running
-
National Taiwan University Hospital
Taipei, Taipei, Taiwan Recruiting -
National Taiwan University Hospital
Taipei, Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Cw Lu, A.p.
- Email: biopsycosocial@gmail.com
- Phone: 8860922801375
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive changes after bariatric surgery using VR Neurotracker and Neuropsi testing
This study will test whether bariatric surgery combined with virtual‑reality Neurotracker sessions improves thinking and memory in adults with morbid obesity scheduled for surgery.
-
Short-term effects of ultra-processed foods on metabolism
This project will test whether a short-term diet high in ultra-processed foods versus a nutrient- and energy-matched low-UPF diet changes appetite and how much adults with BMI 18.5–30 eat.
-
Validating lab assays, IV catheter techniques, and devices for endocrine, cardiometabolic, and musculoskeletal conditions
This project will test whether laboratory assays, IV catheter methods, and equipment give consistent, reliable results in adults with or without obesity-related, metabolic, or musculoskeletal conditions.
-
Improving team-based biopsychosocial training so clinics can deliver recommended obesity care
This project will test two training methods to help clinic teams (primary care clinicians, behavioral health staff, dietitians, and community health workers) deliver USPSTF-recommended obesity care to patients at Federally Qualified Health Centers.
-
See if same day discharge after bariatric surgery is safe for select patients
This trial tests whether people having sleeve gastrectomy or gastric bypass can go home the same day or should stay at least one night, to see if ER visits within a week differ.
-
Evaluating smoking cessation using e-cigarettes and nicotine therapy
This study is testing whether using e-cigarettes or nicotine replacement therapy can help people with obesity who smoke quit smoking and manage their weight better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.